In conclusion, the data presented in this review, obtained from in vitro and in vivo experiments and from clinical samples, strongly supports the role of IL-6 and OSM on EMP promotion and suggests that both cytokines could be potential therapeutic targets to halt tumour progression by blocking EMP. The gene discussed is MAEA; the disease is neoplasm.